Hrt Financial LP Night Hawk Biosciences, Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.26 - $0.51 $14,277 - $28,005	54,912 New	54,912 $24,000
Q2 2021 Aug 16, 2021	SELL	$5.78 - $9.6 $268,787 - $446,428	-46,503 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.67 - $12.54 $20,684 - $45,745	-3,648 Reduced 7.27%	46,503 $338,000
Q4 2020 Feb 16, 2021	BUY	$5.28 - $9.59 $264,797 - $480,948	50,151 New	50,151 $268,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.